Maetzold’s presentation will take place during the AZAdvances Life Science Innovation Showcase on October 6Continue reading
Author Archive: AZBio
UArizona Cancer Center Researchers Identify Mechanism for Slowing Cancer Growth
A newly discovered mechanism for controlling blood vessel growth in tumors points to possible strategies for developing new therapeutic interventions to overcome drug resistance.
Humabiologics becomes ISO 13485 Certified and GMP Compliant Manufacturer
The ISO 13485:2016 registration positions Humabiologics among the first global providers of GMP (Good Manufacturing Practices) grade human-derived biomaterials to support and expedite the future development of human regenerative therapies and tissue models for drug discovery through clinically relevant high-quality products. Continue reading
Are Innovations in Chemistry Your Thing? Apply to Present in the Scorpion Pit
RMRM 2021 Scorpion Pit Competition
Tucson Marriott University Park, Tucson, Arizona
Thursday, October 21, 2021 5:00 – 7:00 PMContinue reading
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
Trial provides proof of concept for this new metabolically targeted, rapidly acting technology platform for brain tumors and other lethal cancersContinue reading
Here’s how the Arizona bioscience sector is pioneering innovations
The pace of medical innovation is accelerating around the world and right here in the Arizona bioscience sector. Biomedical innovators are pioneering in the fields of diagnostics, treatments, medical devices, and health technologies.Continue reading
DNA modifications could be used to determine the progression of severe liver disease
TGen-led study suggests that modifications of DNA at specific genomic sites correlate with levels of fibrosis in NAFLD and could be used to diagnose the severity of this conditionContinue reading
Roche opens access to pathology imaging tools to improve patient care
- Roche launches the Digital Pathology Open Environment, encouraging collaboration among software developers to improve patient outcomes and expand personalised healthcare through innovative image analysis tools
- Artificial intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment
- Open digital pathology environments can break down barriers to allow for rapid technology advances across industry and research partners, which is critical in developing next-generation diagnostic tests
PathogenDx is a 2021 AZBio Fast Lane Honoree
“Science-based companies are in a unique position to leverage what they know to find solutions to new challenges,” stated AZBio president & CEO Joan Koerber-Walker. “PathogenDx is an innovative company that has productized multiple assays to combat the war with pathogens. The ability to adapt is at the core of the company’s DNA, making them a shining example of how Arizona Bioscience Companies are stepping up to meet the challenges of our time.”Continue reading
Humabiologics, Inc. is a 2021 AZBio Fast Lane Honoree
Humabiologics is being honored with a 2021 AZBio Fast Lane Award for the progress they are making in commercializing and delivering products that can help accelerate the pace of medical innovation. Continue reading